- Home
- CVGI vs BRNS Comparison
CVGI vs BRNS Comparison
Compare CVGI & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVGI
- BRNS
- Stock Information
- Founded
- CVGI 2000
- BRNS 2016
- Country
- CVGI United States
- BRNS United Kingdom
- Employees
- CVGI N/A
- BRNS N/A
- Industry
- CVGI Auto Parts:O.E.M.
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- CVGI Consumer Discretionary
- BRNS Health Care
- Exchange
- CVGI Nasdaq
- BRNS Nasdaq
- Market Cap
- CVGI 34.0M
- BRNS 40.0M
- IPO Year
- CVGI 2004
- BRNS 2021
- Fundamental
- Price
- CVGI $1.31
- BRNS $0.87
- Analyst Decision
- CVGI Buy
- BRNS Strong Buy
- Analyst Count
- CVGI 1
- BRNS 1
- Target Price
- CVGI $10.00
- BRNS $3.00
- AVG Volume (30 Days)
- CVGI 275.5K
- BRNS 39.4K
- Earning Date
- CVGI 08-04-2025
- BRNS 08-07-2025
- Dividend Yield
- CVGI N/A
- BRNS N/A
- EPS Growth
- CVGI N/A
- BRNS N/A
- EPS
- CVGI N/A
- BRNS N/A
- Revenue
- CVGI $698,524,000.00
- BRNS $14,969,000.00
- Revenue This Year
- CVGI N/A
- BRNS N/A
- Revenue Next Year
- CVGI $7.37
- BRNS N/A
- P/E Ratio
- CVGI N/A
- BRNS N/A
- Revenue Growth
- CVGI N/A
- BRNS 4381.74
- 52 Week Low
- CVGI $0.81
- BRNS $0.64
- 52 Week High
- CVGI $5.69
- BRNS $1.65
- Technical
- Relative Strength Index (RSI)
- CVGI 49.63
- BRNS 44.19
- Support Level
- CVGI $1.31
- BRNS $0.96
- Resistance Level
- CVGI $1.41
- BRNS $0.93
- Average True Range (ATR)
- CVGI 0.10
- BRNS 0.06
- MACD
- CVGI -0.02
- BRNS -0.02
- Stochastic Oscillator
- CVGI 21.21
- BRNS 15.14
About CVGI Commercial Vehicle Group Inc.
Commercial Vehicle Group Inc is a provider of systems, assemblies, and components to the commercial vehicle market and the electric vehicle markets. It delivers solutions to complex design, engineering, and manufacturing problems while creating positive change for customers, industries, and communities. Its operating segments are Vehicle Solutions, Electrical Systems, and Aftermarket and Accessories. The company makes the majority of its revenue from Vehicle Solutions. The group generates revenue from its products including seating systems, plastic components, electrical wire harnesses, mirrors, wipers, and other accessories. Its geographic regions are North America, Europe and Asia-Pacific.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.